PROTALIX LTD.

AIR DNASE

Pharmaceutical preparations for the treatment of cystic fibrosis;DNASE;

LIFLYSO

pharmaceuticals for use in the treatment of lysosomal storage diseases;

PROCELLEX

[ Bioreactor for cell culturing ];[ Chemical, biochemical, biological and biotechnological preparations and substances for scientific and medical research use, namely, recombinant vectors for cloning; proteins and reagents for scientific and medical research use, namely, for use in recombinant protein expression in cells; recombinant vectors and reagents for expressing recombinant DNA for industrial, scientific, and medical research use; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for industrial, scientific, and medical research use in laboratories, diagnostics and analytics; chemical, biochemical, biological and biotechnological preparations and substances, namely, cell growth support structures medium and substrates for use in cell cultures for industrial, scientific and medical research; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules from recombinant proteins or peptides expressed in cell cultures, namely, cell growth support structures and substrates for use in cell cultures, recombinant vectors for cloning and reagents for expression of recombinant proteins; none of the foregoing being diagnostic assays for scientific, research, clinical, or medical laboratory use ];Providing medical and scientific research equipment to others for culturing cells used to produce biopharmaceuticals, namely, recombinant proteins; research and development for others in the field of genetically engineered plants and plant cells for producing biopharmaceuticals, namely, recombinant proteins; development of new technology for others in the field of recombinant biotechnology; product research and development; scientific research and industrial research for others, namely, drug discovery, cell discovery, discovery of recombinant proteins, gene research, enzyme research, molecular research, genomics and gene expression research and development; technical consultation in the field of biotechnology and in the field of recombinant production technology;

UPLYSO

pharmaceuticals for use in the treatment of lysosomal storage diseases;